Article
Identification of novel therapeutic targets for polyglutamine toxicity disorders that target mitochondrial fragmentation
2021-10-20
Abstract excerpt
Huntington’s disease (HD) is one of at least nine polyglutamine toxicity disorders caused by a trinucleotide CAG repeat expansion, all of which lead to age-onset neurodegeneration. Mitochondrial dynamics and function are disrupted in HD and other polyglutamine toxicity disorders. While multiple studies have found beneficial effects from decreasing mitochondrial fragmentation in HD models by disrupting the mitochon...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4345c1c8-1a52-5f2c-beeb-83a30cba8050
- DOI
- 10.1101/2021.10.19.465059
